Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.0 - $3.0 $29,406 - $44,109
-14,703 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$2.9 - $3.47 $150 - $180
52 Added 0.35%
14,703 $43,000
Q4 2021

Feb 14, 2022

SELL
$3.17 - $4.09 $8,321 - $10,736
-2,625 Reduced 15.19%
14,651 $47,000
Q3 2021

Nov 15, 2021

BUY
$3.01 - $3.77 $9,183 - $11,502
3,051 Added 21.45%
17,276 $61,000
Q2 2021

Aug 16, 2021

SELL
$2.86 - $3.61 $1,275 - $1,610
-446 Reduced 3.04%
14,225 $44,000
Q1 2021

May 17, 2021

SELL
$2.61 - $4.08 $22,511 - $35,190
-8,625 Reduced 37.02%
14,671 $48,000
Q4 2020

Feb 16, 2021

SELL
$1.82 - $2.61 $6,448 - $9,247
-3,543 Reduced 13.2%
23,296 $61,000
Q3 2020

Nov 16, 2020

BUY
$2.02 - $3.02 $27,581 - $41,235
13,654 Added 103.56%
26,839 $56,000
Q2 2020

Aug 14, 2020

BUY
$2.12 - $3.22 $27,952 - $42,455
13,185 New
13,185 $30,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $33.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.